Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

IGC Pharma (IGC) Current Leases (2023 - 2025)

IGC Pharma (IGC) has disclosed Current Leases for 3 consecutive years, with $9000.0 as the latest value for Q3 2025.

  • Quarterly Current Leases fell 93.28% to $9000.0 in Q3 2025 from the year-ago period, while the trailing twelve-month figure was $9000.0 through Sep 2025, down 93.28% year-over-year, with the annual reading at $94000.0 for FY2025, 24.19% down from the prior year.
  • Current Leases for Q3 2025 was $9000.0 at IGC Pharma, down from $62000.0 in the prior quarter.
  • The five-year high for Current Leases was $134000.0 in Q3 2024, with the low at $9000.0 in Q3 2025.
  • Average Current Leases over 3 years is $104111.1, with a median of $124000.0 recorded in 2023.
  • The sharpest move saw Current Leases changed 0.0% in 2024, then tumbled 93.28% in 2025.
  • Over 3 years, Current Leases stood at $124000.0 in 2023, then changed by 0.0% to $124000.0 in 2024, then tumbled by 92.74% to $9000.0 in 2025.
  • According to Business Quant data, Current Leases over the past three periods came in at $9000.0, $62000.0, and $94000.0 for Q3 2025, Q2 2025, and Q1 2025 respectively.